These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
135 related articles for article (PubMed ID: 16995314)
1. [Effect of transplantation of wild-type bone marrow stem cells in mouse model of familial amyotrophic lateral sclerosis]. Huang H; Zhang C; Zhao CP; Yao XL; Xi J Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2006 Aug; 28(4):562-6. PubMed ID: 16995314 [TBL] [Abstract][Full Text] [Related]
2. A novel cell transplantation protocol and its application to an ALS mouse model. Morita E; Watanabe Y; Ishimoto M; Nakano T; Kitayama M; Yasui K; Fukada Y; Doi K; Karunaratne A; Murrell WG; Sutharsan R; Mackay-Sim A; Hata Y; Nakashima K Exp Neurol; 2008 Oct; 213(2):431-8. PubMed ID: 18691571 [TBL] [Abstract][Full Text] [Related]
3. Combined immunosuppressive agents or CD4 antibodies prolong survival of human neural stem cell grafts and improve disease outcomes in amyotrophic lateral sclerosis transgenic mice. Yan J; Xu L; Welsh AM; Chen D; Hazel T; Johe K; Koliatsos VE Stem Cells; 2006 Aug; 24(8):1976-85. PubMed ID: 16644922 [TBL] [Abstract][Full Text] [Related]
4. The potential for the use of mononuclear cells from human umbilical cord blood in the treatment of amyotrophic lateral sclerosis in SOD1 mice. Chen R; Ende N J Med; 2000; 31(1-2):21-30. PubMed ID: 10998753 [TBL] [Abstract][Full Text] [Related]
5. Neural stem cells LewisX+ CXCR4+ modify disease progression in an amyotrophic lateral sclerosis model. Corti S; Locatelli F; Papadimitriou D; Del Bo R; Nizzardo M; Nardini M; Donadoni C; Salani S; Fortunato F; Strazzer S; Bresolin N; Comi GP Brain; 2007 May; 130(Pt 5):1289-305. PubMed ID: 17439986 [TBL] [Abstract][Full Text] [Related]
6. Therapeutic effects of dl-3-n-butylphthalide in a transgenic mouse model of amyotrophic lateral sclerosis. Feng XH; Yuan W; Peng Y; Liu MS; Cui LY Chin Med J (Engl); 2012 May; 125(10):1760-6. PubMed ID: 22800896 [TBL] [Abstract][Full Text] [Related]
7. [ALA-PDT alleviates graft-versus-host disease in mice following allogenic bone marrow transplantation]. Ran HH; Pan KL; Zhang R; Wang YF Zhongguo Dang Dai Er Ke Za Zhi; 2006 Oct; 8(5):408-12. PubMed ID: 17052403 [TBL] [Abstract][Full Text] [Related]
8. Transgenics, toxicity and therapeutics in rodent models of mutant SOD1-mediated familial ALS. Turner BJ; Talbot K Prog Neurobiol; 2008 May; 85(1):94-134. PubMed ID: 18282652 [TBL] [Abstract][Full Text] [Related]
10. Protective conditioning against GVHD and graft rejection after combined organ and hematopoietic cell transplantation. Strober S Blood Cells Mol Dis; 2008; 40(1):48-54. PubMed ID: 17827036 [TBL] [Abstract][Full Text] [Related]
11. [Experiment study of efficacy on hematopoietic reconstitution and GVHD prophylaxis after mesenchymal cell infused by intra-bone marrow cavity or intravenous in rat BMT models]. Huang K; Huang SL; Zhou DH; Cai Y; Zhang XC; Li Y Zhonghua Xue Ye Xue Za Zhi; 2007 Feb; 28(2):87-92. PubMed ID: 17650667 [TBL] [Abstract][Full Text] [Related]
12. Intrathecal transplantation of human neural stem cells overexpressing VEGF provide behavioral improvement, disease onset delay and survival extension in transgenic ALS mice. Hwang DH; Lee HJ; Park IH; Seok JI; Kim BG; Joo IS; Kim SU Gene Ther; 2009 Oct; 16(10):1234-44. PubMed ID: 19626053 [TBL] [Abstract][Full Text] [Related]
13. [Role of paternal veto cells in preventing graft-versus-host disease after HLA-haploidentical stem cell transplantation in mice]. Wang SB; Guo KY; Hu DM Nan Fang Yi Ke Da Xue Xue Bao; 2008 Jan; 28(1):79-81. PubMed ID: 18227034 [TBL] [Abstract][Full Text] [Related]
14. Treatment of amyotrophic lateral sclerosis patients by autologous bone marrow-derived hematopoietic stem cell transplantation: a 1-year follow-up. Deda H; Inci MC; Kürekçi AE; Sav A; Kayihan K; Ozgün E; Ustünsoy GE; Kocabay S Cytotherapy; 2009; 11(1):18-25. PubMed ID: 19012065 [TBL] [Abstract][Full Text] [Related]
15. [Survival in amyotrophic lateral sclerosis]. Alcaz S; Jarebinski M; Pekmezović T; Marinković Z; Apostolski S Srp Arh Celok Lek; 1997; 125(1-2):19-23. PubMed ID: 17974351 [TBL] [Abstract][Full Text] [Related]
16. Intra-bone marrow-bone marrow transplantation slows disease progression and prolongs survival in G93A mutant SOD1 transgenic mice, an animal model mouse for amyotrophic lateral sclerosis. Ohnishi S; Ito H; Suzuki Y; Adachi Y; Wate R; Zhang J; Nakano S; Kusaka H; Ikehara S Brain Res; 2009 Nov; 1296():216-24. PubMed ID: 19686706 [TBL] [Abstract][Full Text] [Related]
17. Therapeutic benefits of intrathecal protein therapy in a mouse model of amyotrophic lateral sclerosis. Ohta Y; Kamiya T; Nagai M; Nagata T; Morimoto N; Miyazaki K; Murakami T; Kurata T; Takehisa Y; Ikeda Y; Asoh S; Ohta S; Abe K J Neurosci Res; 2008 Oct; 86(13):3028-37. PubMed ID: 18543336 [TBL] [Abstract][Full Text] [Related]
18. [A study of bulbar, upper extremity, and lower extremity motor function preservation at the time that respiratory symptoms appear in ALS]. Kimura F; Fujimura C; Ishida S; Hosokawa T; Sato T; Nakajima H; Furutama D; Sugino M Rinsho Shinkeigaku; 2007 Apr; 47(4):140-6. PubMed ID: 17511283 [TBL] [Abstract][Full Text] [Related]
19. Regular exercise is beneficial to a mouse model of amyotrophic lateral sclerosis. Kirkinezos IG; Hernandez D; Bradley WG; Moraes CT Ann Neurol; 2003 Jun; 53(6):804-7. PubMed ID: 12783429 [TBL] [Abstract][Full Text] [Related]